Sign in

NCT02436941Enrolling by invitation

Radiation Medicine Patient Registry, Loma Linda University Medical Center

Loma Linda University Medical Center Department of Radiation Medicine Patient Registry

Source: ClinicalTrials.gov · Last updated 8 May 2026

Brief summary (registry, in English)

For most cancers, long-term follow-up is the best measure of treatment effectiveness. The Department of Radiation Medicine at Loma Linda University Medical Center operates the James M. Slater, M.D., Proton Treatment and Research Center, the world's first hospital-based proton treatment facility. Patients have been treated at the Center since 1990. Radiation treatment has been expanded and refined since the Center's opening, and these changes have been based primarily on outcomes seen and evaluated in long-term follow-up. The Radiation Medicine Patient Registry (a multi-year database), which began as an IRB-approved study in 2003, including detailed follow-up of study data collected from 1990 and onward, is designed to track all medical information from patients treated with proton therapy and/or conventional X-ray therapy at Loma Linda University Medical Center. Information gathered from patients treated years or even decades ago helps to determine the most effective use of proton and conventional radiation in caring for patients with cancers and other diseases.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
75000 (estimated)
First submitted
27 Mar 2015
Start date
20 Oct 2003
Primary completion date
31 Mar 2040
Lead sponsor
Loma Linda University
NCT number
NCT02436941

What you commit to

  • Study type: Observational
  • Planned participants: 75000
  • From 20 Oct 2003 to the primary completion date, 31 Mar 2040
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • There are no specific exclusion criteria, but patients who are unwilling to sign the ICD will not be included

Who the study is looking for

  • Diagnosis of benign or malignant tumors or other conditions deemed treatable by proton or conventional photon radiotherapy
  • Willingness to sign an Informed Consent Document

Age in the registry: - to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.